Omega Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Omega Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q2 2024.
  • Omega Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $275K, a 76.1% decline year-over-year.
  • Omega Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.74M, a 14% decline year-over-year.
  • Omega Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $2.83M, a 4258% increase from 2022.
  • Omega Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $65K.
  • Omega Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.25M, a 180% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.74M $275K -$878K -76.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.62M $322K -$217K -40.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $2.83M $486K +$344K +242% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $2.49M $655K +$469K +252% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.02M $1.15M +$1.21M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $809K $539K +$744K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $65K $142K +$332K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$267K $186K +$1.49M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1.76M -$58K +$147K +71.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$1.91M -$205K +$341K +62.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$2.25M -$190K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$1.31M -$1.11M -567% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$205K -$12K -6.22% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$546K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q3 2020 -$196K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$193K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.